| 2 | 1/1 | 返回列表 |
| 查看: 1675 | 回復(fù): 1 | |||
[交流]
gliosis和glioma有什么區(qū)別? 已有1人參與
|
|
查了些文獻(xiàn)都沒有談清楚,有大神指點(diǎn)一下嘛 gliosis指膠質(zhì)增生,glioma是膠質(zhì)瘤,但是有時(shí)候又不太能分清楚。 |
木蟲 (小有名氣)
|
Gliosis versus glioma?: don't grade until you know. Marie Rivera-Zengotita Anthony T Yachnis Department of Pathology, Immunology, and Laboratory Medicine, University of Florida College of Medicine, Gainesville, USA. Advances in anatomic pathology (Impact Factor: 3.22). 07/2012; 19(4):239-49. DOI: 10.1097/PAP.0b013e31825c6a04 Source: PubMed ABSTRACT A major challenge in the routine practice of surgical neuropathology is the distinction between reactive astrocytosis, which may be because of non-neoplastic and neoplastic conditions, and a low-grade infiltrating diffuse astrocytoma [World Health Organization (WHO) grade II]. This can be particularly challenging with small biopsies that often yield limited amounts of tissue for pathologic study, especially considering the marked differences in prognosis and therapy after a pathologic diagnosis. This paper will review some basic principles of gliosis as an astrocytic reaction to a wide range of central nervous system insults and focus on some common diagnostic pitfalls such as (1) gliosis associated with brain tumor mimics, including demyelinating disease and infections, (2) gliosis associated with nonglial tumors such as craniopharyngioma, hemangioblastoma, metastases, and central nervous system lymphoma. New diagnostic methods have facilitated the differentiation between reactive astrocytosis and the diffuse gliomas. Of these, the use of mutated isocitrate dehydrogenase-1 (IDH-1) as a marker of diffuse infiltrating astroctomas, oligodendrogliomas, and a subset of glioblastomas (secondary glioblastomas) is particularly exciting for tissue diagnosis and patient prognosis. In addition IDH-1 may be useful to distinguish a diffuse infiltrating glioma from low-grade "focal" neoplasms such as the pilocytic astocytoma in histologically ambiguous cases. The discovery of BRAF mutations as molecular signatures of some pilocytic astrocytomas, gangliogliomas, and pleomorphic xanthoastrocytomas has provided another diagnostic tool for the pathologist. Only after a definitive diagnosis of a diffuse infiltrating glioma or a focal glioma is made should a tumor grade be applied and some practical issues in current glioma grading are provided. |
| 2 | 1/1 | 返回列表 |
| 最具人氣熱帖推薦 [查看全部] | 作者 | 回/看 | 最后發(fā)表 | |
|---|---|---|---|---|
|
[考研] 352求調(diào)劑 +3 | 大米飯! 2026-03-22 | 3/150 |
|
|---|---|---|---|---|
|
[考研] 北科281學(xué)碩材料求調(diào)劑 +6 | tcxiaoxx 2026-03-20 | 6/300 |
|
|
[考研] 308求調(diào)劑 +3 | 墨墨漠 2026-03-21 | 3/150 |
|
|
[考研] 尋找調(diào)劑 +4 | 倔強(qiáng)芒? 2026-03-21 | 4/200 |
|
|
[考研] 269專碩求調(diào)劑 +6 | 金恩貝 2026-03-21 | 6/300 |
|
|
[考研] 303求調(diào)劑 +5 | 安憶靈 2026-03-22 | 6/300 |
|
|
[考研] 一志愿華中科技大學(xué)071000,求調(diào)劑 +4 | 沿岸有貝殼6 2026-03-21 | 4/200 |
|
|
[考研] 286求調(diào)劑 +10 | Faune 2026-03-21 | 10/500 |
|
|
[考研] 求調(diào)劑 +3 | 白QF 2026-03-21 | 3/150 |
|
|
[考研] 307求調(diào)劑 +3 | wyyyqx 2026-03-17 | 3/150 |
|
|
[考研] 一志愿武理材料305分求調(diào)劑 +6 | 想上岸的鯉魚 2026-03-18 | 7/350 |
|
|
[考研] 274求調(diào)劑 +10 | S.H1 2026-03-18 | 10/500 |
|
|
[考研] 南京大學(xué)化學(xué)376求調(diào)劑 +3 | hisfailed 2026-03-19 | 6/300 |
|
|
[考研] 一志愿中海洋材料工程專碩330分求調(diào)劑 +8 | 小材化本科 2026-03-18 | 8/400 |
|
|
[考研] 290求調(diào)劑 +7 | ^O^乜 2026-03-19 | 7/350 |
|
|
[考研] 材料學(xué)碩318求調(diào)劑 +5 | February_Feb 2026-03-19 | 5/250 |
|
|
[考博] 申博26年 +3 | 八6八68 2026-03-19 | 3/150 |
|
|
[考研] 085600材料與化工求調(diào)劑 +6 | 緒幸與子 2026-03-17 | 6/300 |
|
|
[考研] 0854可跨調(diào)劑,一作一項(xiàng)核心論文五項(xiàng)專利,省、國(guó)級(jí)證書40+數(shù)一英一287 +8 | 小李0854 | 8/400 |
|
|
[考研] 考研求調(diào)劑 +3 | 橘頌. 2026-03-17 | 4/200 |
|